title: No tumor-free waiting period after treatment of multilocular cystic renal cell carcinoma: a new case and review of the literature.
abstract: Most pretransplant malignancies require a tumor-free waiting period before transplantation. End-stage renal disease (ESRD) patients have an increased risk of renal cell carcinoma (RCC), which is mostly detected from routine screening during pre-kidney transplant evaluation. RCC must be quiescent prior to kidney transplantation. However, the tumor-free waiting period for RCC varies depending on the types of RCC. Multilocular cystic RCC (MCRCC), one subtype of clear cell RCC, has low malignant potential and may not require a tumor-free waiting period. We report a case of an ESRD patient with a newly diagnosed MCRCC that was found during routine pre-kidney transplant evaluation. A plan for kidney transplantation within 6 months of successful tumor removal by nephrectomy was made. The literature regarding MCRCC in kidney transplantation is reviewed.
authors.affiliation: Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Ga., USA.
authors.forename: Ekamol
authors.initials: E
authors.lastname: Tantisattamo
authors.forename: April
authors.initials: A
authors.lastname: Elam
authors.forename: Jason
authors.initials: J
authors.lastname: Cobb
authors.forename: Carla L
authors.initials: CL
authors.lastname: Ellis
authors.forename: James L
authors.initials: JL
authors.lastname: Bailey
mesh_terms: D002292:Carcinoma, Renal Cell / Q000150:complications / Q000473:pathology* / Q000601:surgery; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery*; D007680:Kidney Neoplasms / Q000150:complications / Q000473:pathology* / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D013997:Time Factors